Molina Healthcare Inc (MOH) Lifted to “Buy” at ValuEngine

ValuEngine upgraded shares of Molina Healthcare Inc (NYSE:MOH) from a hold rating to a buy rating in a report released on Thursday morning.

A number of other research analysts have also recently commented on the company. Zacks Investment Research upgraded Molina Healthcare from a sell rating to a hold rating in a research note on Monday, November 6th. Morgan Stanley boosted their price objective on Molina Healthcare from $68.00 to $89.00 and gave the stock an overweight rating in a research note on Friday, November 3rd. Jefferies Group LLC boosted their price objective on Molina Healthcare from $64.00 to $74.00 and gave the stock a hold rating in a research note on Friday, November 3rd. Wolfe Research upgraded Molina Healthcare from a market perform rating to an outperform rating in a research note on Monday, October 23rd. Finally, BMO Capital Markets assumed coverage on Molina Healthcare in a research note on Monday, October 16th. They issued a market perform rating and a $70.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company. Molina Healthcare presently has an average rating of Hold and an average price target of $64.30.

Molina Healthcare (NYSE MOH) traded up $0.30 during mid-day trading on Thursday, reaching $76.90. The company’s stock had a trading volume of 1,006,000 shares, compared to its average volume of 1,585,734. Molina Healthcare has a 1 year low of $42.56 and a 1 year high of $80.65. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.24 and a current ratio of 1.29. The stock has a market capitalization of $4,390.53, a P/E ratio of 23.88 and a beta of 0.91.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). The firm had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $4.95 billion. Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. Molina Healthcare’s revenue was up 10.7% on a year-over-year basis. During the same period last year, the firm posted $0.85 EPS. equities analysts predict that Molina Healthcare will post -3.88 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Molina Healthcare Inc (MOH) Lifted to “Buy” at ValuEngine” was posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://transcriptdaily.com/2017/11/13/molina-healthcare-inc-moh-lifted-to-buy-at-valuengine.html.

In related news, Director Daniel Cooperman sold 4,500 shares of the stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $78.79, for a total value of $354,555.00. Following the completion of the transaction, the director now directly owns 9,087 shares of the company’s stock, valued at approximately $715,964.73. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $60.00, for a total value of $60,000.00. The disclosure for this sale can be found here. Insiders have sold 368,458 shares of company stock valued at $24,010,639 over the last ninety days. Corporate insiders own 6.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of MOH. LS Investment Advisors LLC grew its holdings in Molina Healthcare by 40.9% in the 2nd quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock worth $127,000 after buying an additional 531 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in Molina Healthcare in the second quarter worth approximately $136,000. Riverhead Capital Management LLC lifted its position in Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock worth $170,000 after purchasing an additional 963 shares during the period. Sabal Trust CO acquired a new stake in Molina Healthcare in the third quarter worth approximately $206,000. Finally, Bronfman E.L. Rothschild L.P. lifted its position in Molina Healthcare by 478.7% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock worth $229,000 after purchasing an additional 2,743 shares during the period. 95.88% of the stock is owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply